Sanofi Consumer Healthcare India Limited (NSE:SANOFICONR)
India flag India · Delayed Price · Currency is INR
4,192.90
-164.10 (-3.77%)
Mar 13, 2026, 3:29 PM IST

NSE:SANOFICONR Income Statement

Millions INR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Dec '23
8,7847,2458,331
Revenue Growth (YoY)
21.24%-13.04%-
Cost of Revenue
2,3011,8772,291
Gross Profit
6,4835,3686,041
Selling, General & Admin
1,2881,2351,050
Other Operating Expenses
2,1051,4271,709
Operating Expenses
3,5102,7072,786
Operating Income
2,9732,6613,255
Interest Expense
-20-39-
Interest & Investment Income
-11860
Currency Exchange Gain (Loss)
-1-
Other Non Operating Income (Expenses)
184111.5
EBT Excluding Unusual Items
3,1372,7523,317
Asset Writedown
--29-
Other Unusual Items
66-255-27
Pretax Income
3,2032,4683,290
Income Tax Expense
802658816
Net Income
2,4011,8102,474
Net Income to Common
2,4011,8102,474
Net Income Growth
32.65%-26.82%-
Shares Outstanding (Basic)
232323
Shares Outstanding (Diluted)
232323
Shares Change (YoY)
-0.02%--
EPS (Basic)
104.2778.59107.40
EPS (Diluted)
104.2778.59107.40
EPS Growth
32.67%-26.82%-
Free Cash Flow
1,6724,291-66
Free Cash Flow Per Share
72.61186.32-2.87
Dividend Per Share
75.00055.000-
Dividend Growth
36.36%--
Gross Margin
73.80%74.09%72.51%
Operating Margin
33.85%36.73%39.07%
Profit Margin
27.33%24.98%29.69%
Free Cash Flow Margin
19.04%59.23%-0.79%
EBITDA
3,0902,6833,282
EBITDA Margin
35.18%37.03%39.40%
D&A For EBITDA
1172227
EBIT
2,9732,6613,255
EBIT Margin
33.85%36.73%39.07%
Effective Tax Rate
25.04%26.66%24.81%
Revenue as Reported
8,9687,3758,393
Advertising Expenses
-181-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.